JOHNS HOPKINS UNIVERSITY
๐ณ๐ฆNamibia
- Country
- ๐ณ๐ฆNamibia
- Ownership
- -
- Established
- 1876-01-01
- Employees
- 19.4K
- Market Cap
- -
- Website
- https://www.jhu.edu/
Macrolides to Prevent Exacerbations of Asthma and Chronic Obstructive Pulmonary Disease
Phase 2
Terminated
- Conditions
- AsthmaChronic Obstructive Pulmonary Disease
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2013-05-13
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 18
- Registration Number
- NCT00181272
- Locations
- ๐บ๐ธ
Johns Hopkins Hospital, Baltimore, Maryland, United States
Atkins Diet for Difficult-to-Control Headaches in Teenagers
Phase 1
Completed
- Conditions
- Chronic Daily Headache
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2009-07-02
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 10
- Registration Number
- NCT00181064
- Locations
- ๐บ๐ธ
Johns Hopkins Hospital, Baltimore, Maryland, United States
Imaging Techniques for Identifying Factors of Sudden Cardiac Death Risk
Recruiting
- Conditions
- Sudden Cardiac Death
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2025-01-10
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 400
- Registration Number
- NCT00181233
- Locations
- ๐บ๐ธ
Johns Hopkins Medical Institutions, Baltimore, Maryland, United States
Intravenous Allopurinol in Heart Failure
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2017-05-30
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 18
- Registration Number
- NCT00181155
- Locations
- ๐บ๐ธ
Johns Hopkins Hospital, Baltimore, Maryland, United States
Levetiracetam for Benign Rolandic Epilepsy
Phase 4
Completed
- Conditions
- Epilepsy
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2009-03-27
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 6
- Registration Number
- NCT00181116
- Locations
- ๐บ๐ธ
Johns Hopkins Hospital, Baltimore, Maryland, United States
Reducing Asthma Disparities by Improving Provider-Patient Communication
Completed
- Conditions
- Asthma
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2018-08-21
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 350
- Registration Number
- NCT00181194
- Locations
- ๐บ๐ธ
Johns Hopkins Asthma And Allergy Center, Baltimore, Maryland, United States
Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma
Phase 1
Withdrawn
- Conditions
- Nasopharyngeal Carcinoma
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2020-05-18
- Lead Sponsor
- Johns Hopkins University
- Registration Number
- NCT00181220
- Locations
- ๐ธ๐ฌ
Johns Hopkin Singapore International Medical Center, Singapore, Singapore
Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide
Phase 2
Completed
- Conditions
- Idiopathic Pulmonary Fibrosis (IPF)
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2010-06-22
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 19
- Registration Number
- NCT00162760
- Locations
- ๐บ๐ธ
Johns Hopkins School of Medicine, Baltimore, Maryland, United States
Effect of Anti-IgE in Non-Allergic Asthma
- First Posted Date
- 2005-09-13
- Last Posted Date
- 2017-08-28
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 29
- Registration Number
- NCT00162773
- Locations
- ๐บ๐ธ
Johns Hopkins Asthma and Allergy Center, Baltimore, Maryland, United States
Anterior Pituitary Function in Patients With Hydrocephalus
Not Applicable
Terminated
- Conditions
- Normal Pressure Hydrocephalus
- First Posted Date
- 2005-09-08
- Last Posted Date
- 2010-03-02
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 30
- Registration Number
- NCT00149721
- Locations
- ๐บ๐ธ
GCRC Johns Hopkins University, Baltimore, Maryland, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath